Skip to main content

Completed · United Kingdom · Pharma and biotech

Dipharma acquires LogixX Pharma.

Dipharma, a Swiss specialty pharmaceutical company for rare diseases based in Chiasso, completed on 6 November 2026 the acquisition of LogixX Pharma, a specialty pharmaceutical company in Theale, Berkshire, that supplies medicines for rare and metabolic diseases to the NHS and homecare providers and has been Dipharma's UK partner for nearly ten years. The deal was done through the purchase of LogixX's parent company; terms were not disclosed. The deal completed on 6 November 2026.

SigningDay 100

Announced 6 November 2026 · Day 100 on 14 February 2027

Buyer
Dipharma SA ·Chiasso, Switzerland
Target
LogixX Pharma Limited ·Theale, United Kingdom
Type
Acquisition
Announced
6 November 2026
Completed
6 November 2026
Value
Not disclosed
People
Not stated in the release
Last checked
9 November 2026

The people side in the United Kingdom

Related deals

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe